Enable Accessibility Enable Accessibility

The research publication of the development of therapeutics for NGLY1 deficiency in T-CiRA Joint Program were published online in Human Molecular Genetics on April 7th ,2020.

April 10, 2020

The research publication of the development of therapeutics for NGLY1 deficiency in T-CiRA Joint Program were published online in Human Molecular Genetics on April 7th, 2020.

https://academic.oup.com/hmg/advance-article/doi/10.1093/hmg/ddaa059/5817124?guestAccessKey=a99601eb-7468-4237-8173-5b4a108a64d5

 

Paper Details

  • Journal: Human Molecular Genetics
  • Title: Ngly1−/− rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems
  • Authors: Makoto Asahina1,3, Reiko Fujinawa1,2, Sayuri Nakamura4, Kotaro Yokoyama4, Ryuichi Tozawa1,3, and Tadashi Suzuki1,2
  • Author Affiliations:

1 Takeda-CiRA Joint Program (T-CiRA), 2518555 Kanagawa, Japan,

2 Glycometabolic Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, RIKEN, 3510198 Saitama, Japan,

3 T-CiRA Discovery, Takeda Pharmaceutical Company Ltd., 2518555 Kanagawa, Japan

4 Nonclinical Safety Research, Axcelead Drug Discovery Partners Inc., 2510012 Kanagawa, Japan.